FTC’s challenge is the culmination of years of investigation, but choice of venue and theories of harm reveal potential weaknesses....more
10/2/2024
/ Administrative Proceedings ,
Affiliates ,
Drug Pricing ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
FTC Act ,
Group Purchasing Organizations (GPO) ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Rebates ,
Section 5 ,
Supply Chain